EMV Capital plc is a venture capital firm specializing in seed, growth capital, early and mid stage investments. The firm focuses to invest in sustainability, life science, technology, transformative biomedical, deep tech, semiconductors, industrials, robotics, AI and healthcare technologies focusing on digital health, diagnostics, and therapeutics sectors. It also prefers to invest in companies that significantly improve the health and well-being of people with chronic diseases. Within digital health it focuses on data analytics, wearable technologies, and devices. The firm seeks to invest in companies based in European developed markets, United Kingdom and in the United States. It typically invests up to £15 million ($20.32 million), but may consider larger amounts. It prefers to hold a controlling interest in all principal subsidiaries. The firm prefers to invest through its balance sheet investments. EMV Capital plc was founded on 12 April 2012 and is based in London, United Kingdom with additional office in London, United Kingdom.…
EMV Capital plc Stock Price Prediction: Today, Tomorrow, Next Week (EMVC/GBX)
EMV Capital (LON: EMVC) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Asset Management industry, part of the Financial Services sector, and reports about 21 employees.
The shares were at 45.00 GBp on 20 November 2026, down 1.1% over 52 weeks. Its 52-week range is 40.00 GBp to 62.00 GBp: the price is 27.4% below the high and 12.5% above the low.
Its market capitalisation is 12.69M GBP.
EMV Capital reports return on equity of -0.1%, an operating margin of -196.0% and revenue up 22.1% year over year.
Its debt exceeds its cash by 154.00K GBP, a debt-to-equity ratio of 0.17. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. One analyst covers the stock; their mean price target of 128.00 GBp is 184.4% above the current price.
No upcoming events tracked.